Your browser doesn't support javascript.
loading
The prolyl hydroxylase inhibitor molidustat fails to restore erythropoietin production in the fibrotic kidney.
Schley, Gunnar; Hartner, Andrea.
Affiliation
  • Schley G; Department of Nephrology and Hypertension, Friedrich-Alexander University Erlangen-Nürnberg (FAU), University Hospital Erlangen, Erlangen, Germany.
  • Hartner A; Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander University Erlangen-Nürnberg (FAU), University Hospital Erlangen, Erlangen, Germany.
Acta Physiol (Oxf) ; 235(4): e13858, 2022 08.
Article in En | MEDLINE | ID: mdl-35768895
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Erythropoietin / Renal Insufficiency, Chronic / Prolyl-Hydroxylase Inhibitors Limits: Humans Language: En Journal: Acta Physiol (Oxf) Journal subject: FISIOLOGIA Year: 2022 Document type: Article Affiliation country: Alemania
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Erythropoietin / Renal Insufficiency, Chronic / Prolyl-Hydroxylase Inhibitors Limits: Humans Language: En Journal: Acta Physiol (Oxf) Journal subject: FISIOLOGIA Year: 2022 Document type: Article Affiliation country: Alemania